nach oben

Erschienen in:

01.04.2008 | Review Article

The role of mannose-binding lectin in systemic lupus erythematosus

verfasst von: Odirlei André Monticielo, Tamara Mucenic, Ricardo Machado Xavier, João Carlos Tavares Brenol, José Artur Bogo Chies

Erschienen in: Clinical Rheumatology | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Susceptibility to systemic lupus erythematosus (SLE) is associated with genetic, hormonal, immunological, and environmental factors. Many genes have been related with the appearance of SLE, including several loci that code different complement components and their receptors. Some genetic deficiencies of complement molecules are strongly associated with SLE, probably because these deficiencies could cause decreased clearance of apoptotic cell material. As a consequence of the apoptotic material accumulation, high levels of autoantigens can be presented inappropriately to the immune system in an inflammatory context, resulting in an imbalance on the mechanisms of immunological tolerance, immune system activation, and autoantibody production. Recent studies proposed a role to the mannose-binding lectin (MBL) in the SLE physiopathogenesis. This protein activates the complement system, and the presence of several polymorphisms at the promoter and coding regions of the MBL-2 gene determines alterations at the plasma levels of MBL. Some of these polymorphisms have been associated with SLE susceptibility, as well as with clinical and laboratory typical features of this disease, cardiovascular events, and infections. Besides, it has been described that the presence of anti-MBL autoantibodies in sera of SLE patients can influence MBL plasma levels and its functional activity.

Walport MJ (1993) The Roche Rheumatology Prize Lecture. Complement deficiency and disease. Br J Rheumatol 32(4):269–273PubMedCrossRef

Block SR et al (1975) Proceedings: twin studies in systemic lupus erythematosus (SLE). Arthritis Rheum 18(3):285PubMed

Deapen D et al (1992) A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 35(3):311–318PubMedCrossRef

Arnett FC et al (1984) Systemic lupus erythematosus: current state of the genetic hypothesis. Semin Arthritis Rheum 14(1):24–35PubMedCrossRef

Murashima A et al (2004) Long term prognosis of children born to lupus patients. Ann Rheum Dis 63(1):50–53PubMedCrossRef

Croker JA, Kimberly RP (2005) Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol 17(5):529–537PubMedCrossRef

Fraser PA et al (2003) Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: a possible gene–environment interaction for autoimmunity. J Rheumatol 30(2):276–282PubMed

Morel J et al (2003) Polymorphism of HLA-DMA and DMB alleles in patients with systemic lupus erythematosus. J Rheumatol 30(7):1485–1490PubMed

Tsao BP (2004) Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16(5):513–521PubMedCrossRef

10.

Fairhurst AM, Wandstrat AE, Wakeland EK (2006) Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol 92:1–69PubMedCrossRef

11.

Theofilopoulos AN (1995) The basis of autoimmunity. Part II. Genetic predisposition. Immunol Today 16(3):150–159PubMedCrossRef

12.

Pugh-Bernard AE, Cambier JC (2006) B cell receptor signaling in human systemic lupus erythematosus. Curr Opin Rheumatol 18(5):451–455PubMedCrossRef

13.

Tsokos GC et al (2000) Immune cell signaling in lupus. Curr Opin Rheumatol 12(5):355–363PubMedCrossRef

14.

Dommett RM, Klein N, Turner MW (2006) Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 68(3):193–209PubMedCrossRef

15.

Madsen HO et al (1994) A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 40(1):37–44PubMedCrossRef

16.

Sastry K et al (1989) The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med 170(4):1175–1189PubMedCrossRef

17.

Taylor ME et al (1989) Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J 262(3):763–771PubMed

18.

Garred P et al (2003) Mannose-binding lectin deficiency—revisited. Mol Immunol 40(2–4):73–84PubMedCrossRef

19.

Lipscombe RJ et al (1992) High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992 1(9):709–715CrossRef

20.

Sumiya M et al (1991) Molecular basis of opsonic defect in immunodeficient children. Lancet 337(8757):1569–1570PubMedCrossRef

21.

Lipscombe RJ et al (1996) Mutations in the human mannose-binding protein gene: frequencies in several population groups. Eur J Hum Genet 4(1):13–19PubMed

22.

Madsen HO et al (1995) Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155(6):3013–3020PubMed

23.

Madsen HO et al (1998) Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 161(6):3169–3175PubMed

24.

Neonato MG et al (1999) Genetic polymorphism of the mannose-binding protein gene in children with sickle cell disease: identification of three new variant alleles and relationship to infections. Eur J Hum Genet 7(6):679–686PubMedCrossRef

25.

Davies EJ et al (1995) Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 38(1):110–114PubMedCrossRef

26.

Davies EJ et al (1998) Mannose-binding protein gene polymorphism in South African systemic lupus erythematosus. Br J Rheumatol 37(4):465–466PubMedCrossRef

27.

Lau YL et al (1996) Mannose-binding protein in Chinese patients with systemic lupus erythematosus. Arthritis Rheum 39(4):706–708PubMedCrossRef

28.

Garcia-Laorden MI et al (2003) Mannose binding lectin polymorphisms as a disease-modulating factor in women with systemic lupus erythematosus from Canary Islands, Spain. J Rheumatol 30(4):740–746PubMed

29.

Garred P et al (1999) Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 42(10):2145–2152PubMedCrossRef

30.

Horiuchi T et al (2000) Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese. Genes Immun 1(7):464–466PubMedCrossRef

31.

Sullivan KE et al (1996) Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum 39(12):2046–2051PubMedCrossRef

32.

Sullivan KE et al (2003) Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus. Rheumatology (Oxford) 42(3):446–452CrossRef

33.

Villarreal J et al (2001) Mannose binding lectin and FcgammaRIIa (CD32) polymorphism in Spanish systemic lupus erythematosus patients. Rheumatology (Oxford) 40(9):1009–1012CrossRef

34.

Carthy D et al (1997) Mannose-binding lectin gene polymorphism in Greek systemic lupus erythematosus patients. Br J Rheumatol 36(11):1238–1239PubMedCrossRef

35.

Huang YF et al (2003) Increased frequency of the mannose-binding lectin LX haplotype in Chinese systemic lupus erythematosus patients. Eur J Immunogenet 30(2):121–124PubMedCrossRef

36.

Ip WK et al (1998) Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene. Arthritis Rheum 41(9):1663–1668PubMed

37.

Tsutsumi A et al (2001) Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjogren’s syndrome. Genes Immun 2(2):99–104PubMedCrossRef

38.

Takahashi R et al (2005) Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus. Ann Rheum Dis 64(2):311–314PubMedCrossRef

39.

Navarra SV et al (2007) Increased frequency of mannose-binding lectin promoter LX haplotype among Filipinos with systemic lupus erythematosus. Lupus 16(2):147–148PubMedCrossRef

40.

Chies JA (2007) Letter to the editor: on the haplotypic frequencies of the MBL2 gene among human populations. Lupus 16(10):838PubMedCrossRef

41.

Lee YH et al (2005) The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case–control studies and a meta-analysis. Arthritis Rheum 52(12):3966–3974PubMedCrossRef

42.

Font J et al (2006) Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus. Rheumatology 46:76–80PubMedCrossRef

43.

Ohlenschlaeger T et al (2004) Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus. N Engl J Med 351(3):260–267PubMedCrossRef

44.

Calvo-Alen J et al (2006) Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. Arthritis Rheum 54(6):1940–1945PubMedCrossRef

45.

Bertoli AM et al (2006) Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcome. Arthritis Rheum 54(5):1703–1704PubMedCrossRef

46.

Piao W et al (2007) Mannose-binding lectin is a disease-modifying factor in North American patients with systemic lupus erythematosus. J Rheumatol 34(7):1506–1513PubMed

47.

Mok MY et al (2007) Mannose-binding lectin and susceptibility to infection in Chinese patients with systemic lupus erythematosus. J Rheumatol 34(6):1270–1276PubMed

48.

Bultink IE et al (2006) Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus. Arthritis Res Ther 8(6):R183PubMedCrossRef

49.

Seelen MA et al (2003) Autoantibodies against mannose-binding lectin in systemic lupus erythematosus. Clin Exp Immunol 134(2):335–343PubMedCrossRef

50.

Takahashi R et al (2004) Anti-mannose binding lectin antibodies in sera of Japanese patients with systemic lupus erythematosus. Clin Exp Immunol 136(3):585–590PubMedCrossRef

51.

Mok MY et al (2004) Antibodies to mannose binding lectin in patients with systemic lupus erythematosus. Lupus 13(7):522–528PubMedCrossRef

52.

Shoenfeld Y et al (2007) Autoantibodies against protective molecules-C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 1108:227–239PubMedCrossRef

Titel: The role of mannose-binding lectin in systemic lupus erythematosus
verfasst von: Odirlei André Monticielo
Tamara Mucenic
Ricardo Machado Xavier
João Carlos Tavares Brenol
José Artur Bogo Chies
Publikationsdatum: 01.04.2008
Verlag: Springer-Verlag
Erschienen in: Clinical Rheumatology / Ausgabe 4/2008
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-008-0838-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2008

Oral bisphosphonates in treatment of transient osteoporosis

Early spondyloarthropathy: scintigraphic, biological, and clinical findings in MRI-positive patients

Rheumatoid arthritis, periodontal disease and coronary artery disease

Visceral leishmaniasis in a patient with psoriatic arthritis treated with infliximab: reactivation of a latent infection?

Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association